Johnson Pharmacare Financials

BSE: 532154

₹0.47

₹0.00 (0.00%)

As on 04-Sep-2026IST

Market cap

₹26 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

-38.8

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	--	--	--	2.53	3.26	0.76
Total Income	1.58	--	--	2.53	3.26	0.76
Total Expenditure	42.77	0.58	0.20	3.86	3.13	0.76
EBITDA	-42.77	-0.58	-0.20	-1.33	0.13	0.00
Depreciation	--	--	--	--	--	--
EBIT	-42.77	-0.58	-0.20	-1.33	0.13	0.00
Interest	1.32	0.00	0.00	0.00	0.00	--
Other Income	1.58	--	--	--	--	--
Exceptional Items	-14.27	--	--	--	--	--
Profit before Tax	-56.78	-0.58	-0.20	-1.33	0.13	0.00
Provision for Tax	--	--	--	-0.04	0.04	0.00
Profit after Tax	-56.78	-0.58	-0.20	-1.29	0.10	0.00

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	0.44	56.17	56.75	56.95	58.24	58.14
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	21.40	0.61	1.95	1.91	0.61	0.69
Current Liabilities	0.19	1.15	1.13	0.98	1.13	0.65
Total Liabilities	22.03	57.93	59.83	59.83	59.98	59.48

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	19.73	56.56	59.83	59.83	58.89	53.88
Current Assets	2.31	1.36	0.00	0.00	1.09	5.60
Total Assets	22.03	57.93	59.83	59.83	59.98	59.48
Total Debt*	--	0.61	1.95	1.91	0.61	0.69
Net Current Assets	2.11	0.21	-1.13	-0.97	-0.04	4.95
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	-1.91	-0.05	-0.40	4.90	-0.11
Cash Flow from Investing Activities	--	3.27	--	-0.94	-5.01	--
Cash from Financing Activities	--	-1.35	0.05	1.30	-0.08	0.06
Net Cash Inflow / Outflow	--	0.01	0.00	-0.04	-0.19	-0.05

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-0.77	-0.01	0.00	-0.02	0.00	--
Cash EPS (₹)	-1.03	-0.01	0.00	-0.02	0.00	0.00
Adjusted Book Value (₹)	-0.01	1.02	1.03	1.04	0.96	1.06
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.03	0.00	-0.01	0.09	-0.02
Free Cash Flow per Share (₹)	--	-0.03	0.00	-0.01	0.09	-0.02

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	-1.01	-0.33	-2.26	0.23	0.00
ROE (%)	-150.35	-1.03	-0.35	-2.24	0.17	0.00
ROA (%)	-142.03	-0.99	-0.33	-2.16	0.16	0.00
EBIT Margin (%)	--	--	--	-52.57	4.13	0.21
Net Margin (%)	-3,591.40	--	--	-51.11	2.96	0.15
Cash Profit Margin (%)	--	--	--	-51.11	2.96	0.15

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	--	--	-100.00	-22.56	329.37	--
EBIT Growth (%)	-45,889.25	-198.77	85.30	-1,086.27	8,388.78	101.73
Net Profit Growth (%)	-9,870.98	-197.55	84.81	-1,435.47	8,135.39	101.28
EPS Growth (%)	-9,460.19	-194.44	84.68	-1,570.27	--	100.00
Book Value Growth (%)	--	-1.03	-0.34	-2.22	0.17	0.00

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-0.61	--	--	--	667.01	1,272.73
Price / Book Value	-38.84	0.91	0.67	0.42	1.22	0.24
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.15	-88.67	-204.30	-19.23	530.92	9,109.98
Close Price (₹)	0.50	0.93	0.69	0.43	1.17	0.25
High Price (₹)	0.93	1.44	1.38	1.55	1.57	0.35
Low Price (₹)	0.47	0.69	0.36	0.36	0.19	0.11
Market Cap (₹ Cr)	25.85	--	--	23.65	70.95	14.00

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	49.20	0.01	0.03	0.03	0.01	0.01
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	11.89	1.18	0.00	0.00	0.96	8.60
Quick Ratio	11.89	1.18	0.00	0.00	0.96	8.60
Interest Coverage	-41.98	-1,945.00	-217.00	-1,660.63	449.00	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	--	--	--	--	32.18	221.05
Asset Turnover	--	--	--	0.04	0.05	0.01
Receivable days	--	--	--	--	152.68	624.34
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	182.50
Cash Conversion Cycle	--	--	--	--	--	441.84

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.